Back to search

Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

Data up to Jan 2025

Published1994
Citations832
References28
Clinical Trials (1)

Total Citations Per Year

Abstract

References (28)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Statistical Methods for Rates and Proportions, 2nd ed

1981 • 3,735 citations

Partial residuals for the proportional hazards regression model

1982 • 2,578 citations

The Statistical Analysis of Failure Time Data

1982 • 2,300 citations

SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR

1989 • 627 citations

Magnetic-Susceptibility Measurement of Human Iron Stores

1982 • 374 citations

Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload

1977 • 335 citations

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1974 • 331 citations

Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major

1993 • 272 citations

Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major

1985 • 272 citations

Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation Therapy

1993 • 238 citations

The Clinical Approach to Thalassaemia

1984 • 228 citations

Reassessment of the Use of Desferrioxamine B in Iron Overload

1976 • 187 citations

The effect of erythroid hyperplasia on iron balance

1988 • 169 citations

Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major

1990 • 165 citations

Growth and sexual maturation in thalassemia major

1985 • 162 citations

Treatment of Cooley's anemia [see comments]

1990 • 136 citations

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine

1991 • 120 citations

Pulmonary Syndrome in Patients With Thalassemia Major Receiving Intravenous Deferoxamine Infusions

1990 • 112 citations

Iron Excretion in Thalassaemia Major After Administration of Chelating Agents

1962 • 99 citations

Insulin dependent diabetes in thalassaemia.

1988 • 84 citations

Depletion of excessive liver iron stores with desferrioxamine

1984 • 82 citations

Development of iron-chelating agents for clinical use [editorial; comment]

1992 • 76 citations

Vision and hearing during deferoxamine therapy

1990 • 69 citations

Noninvasive Methods for the Early Detection of Hereditary Hemochromatosisa

1988 • 37 citations

Sustained normalization of cardiac function by chelation therapy in thalassaemia major

1989 • 33 citations

10 Management of Cooley's anaemia

1993 • 14 citations

Cited By (0)

Loading...
Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with… (1994) – New England Journal of Medicine | Metascience Observatory Explorer